MXPA02010173A - Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis. - Google Patents
Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.Info
- Publication number
- MXPA02010173A MXPA02010173A MXPA02010173A MXPA02010173A MXPA02010173A MX PA02010173 A MXPA02010173 A MX PA02010173A MX PA02010173 A MXPA02010173 A MX PA02010173A MX PA02010173 A MXPA02010173 A MX PA02010173A MX PA02010173 A MXPA02010173 A MX PA02010173A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptides
- leishmania
- leishmaniasis
- compositions
- vaccines
- Prior art date
Links
- 241000222722 Leishmania <genus> Species 0.000 title abstract 2
- 208000004554 Leishmaniasis Diseases 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se describen composiciones y métodos para prevenir, tratar y detectar Leishmaniasis y estimular respuestas inmunes en pacientes. Los compuestos provistos incluyen polipéptidos que contienen por lo menos una porcion inmunogenica de uno o más antígenos de Leishmania, o de una variante del mismo. También se proporcionan vacunas y composiciones farmacéuticas que comprenden dichos polipéptidos, o polinucleotidos que codifican dichos polipéptidos, y se pueden utilizar, por ejemplo, para la prevencion y terapia de leishmaniasis, así como para la deteccion de una infeccion por Leishmania.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/551,974 US6500437B1 (en) | 1995-09-22 | 2000-04-14 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US09/565,501 US6607731B1 (en) | 1995-09-22 | 2000-05-05 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US09/639,206 US6613337B1 (en) | 1997-02-12 | 2000-08-14 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
PCT/US2001/011254 WO2001079276A2 (en) | 2000-04-14 | 2001-04-05 | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02010173A true MXPA02010173A (es) | 2003-06-04 |
Family
ID=27415636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02010173A MXPA02010173A (es) | 2000-04-14 | 2001-04-05 | Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6613337B1 (es) |
EP (2) | EP1287026B1 (es) |
AR (1) | AR028333A1 (es) |
AT (1) | ATE310746T1 (es) |
AU (1) | AU2001255241A1 (es) |
DE (1) | DE60115230T2 (es) |
ES (2) | ES2391562T3 (es) |
MX (1) | MXPA02010173A (es) |
PT (1) | PT1681301E (es) |
WO (1) | WO2001079276A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ515322A (en) | 1999-05-13 | 2004-03-26 | Wyeth Corp | Adjuvant combination formulations |
EP1255562B1 (en) * | 2000-02-18 | 2008-01-16 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
CZ20031225A3 (cs) * | 2000-11-10 | 2003-10-15 | Wyeth Holdings Corporation | Adjuvantní kombinované prostředky |
BRPI0710155A2 (pt) | 2006-04-10 | 2011-08-23 | Infectious Disease Res Inst Inc | compostos e métodos para diagnóstico e tratamento de leishmaniose |
WO2009012166A1 (en) * | 2007-07-13 | 2009-01-22 | Infectious Disease Research Institute | Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
US8410258B2 (en) | 2008-05-21 | 2013-04-02 | Infections Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
BRPI0912768A2 (pt) | 2008-05-21 | 2016-05-17 | Infectious Disease Res Inst | vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose |
US8231881B2 (en) | 2008-07-03 | 2012-07-31 | Infectious Disease Research Institute | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
BRPI0900961B8 (pt) * | 2009-03-23 | 2021-07-13 | Fundacao Oswaldo Cruz | métodos e kit para diagnóstico de leishmaniose |
CN102483413A (zh) * | 2009-07-13 | 2012-05-30 | 热体实验室有限公司 | 使用核糖体蛋白提取物(rpe)的寄生虫病如利什曼病的诊断 |
WO2014091463A1 (pt) * | 2012-12-14 | 2014-06-19 | Universidade Federal De Minas Gerais - Ufmg | Processo para produção de proteínas recombinantes de leishmania e uso em kit para diagnóstico e vacina contra leishmanioses |
ES2728865T3 (es) | 2013-03-28 | 2019-10-29 | Infectious Disease Res Inst | Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis |
US20140356391A1 (en) * | 2013-05-29 | 2014-12-04 | Jose Antonio O'Daly | Amino acid sequences for clinical remission of psoriasis and related diseases. |
JP2016053535A (ja) * | 2014-09-04 | 2016-04-14 | 国立大学法人 東京大学 | 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870006A (en) | 1986-07-24 | 1989-09-26 | Codon | Antigenic material for a chagas' disease detection system |
US5411865A (en) | 1993-01-15 | 1995-05-02 | Iasys Corporation | Method of detecting anti-leishmania parasite antibodies |
US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
PT804581E (pt) | 1994-04-22 | 2002-02-28 | Corixa Corp | Compostos e metodos para a estimulacao e reforco das respostas imunitarias protectoras e da producao de il-12 |
US6013268A (en) | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5879687A (en) | 1994-04-22 | 1999-03-09 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5876735A (en) | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5912166A (en) | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US5965142A (en) | 1995-08-04 | 1999-10-12 | Corixa Corporation | Polypeptides and methods for the detection of L. tropica infection |
US5834592A (en) | 1995-09-22 | 1998-11-10 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US5744593A (en) * | 1996-02-15 | 1998-04-28 | Heska Corporation | Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
US5910306A (en) | 1996-11-14 | 1999-06-08 | The United States Of America As Represented By The Secretary Of The Army | Transdermal delivery system for antigen |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US5846748A (en) | 1996-11-15 | 1998-12-08 | The Council Of Scientific & Industrial Research | Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate |
BR9807332A (pt) | 1997-02-12 | 2000-10-31 | Corixa Corp | Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose |
DE69931518T2 (de) * | 1998-12-23 | 2006-12-21 | C.B.F. Leti, S.A., Tres Cantos | Chimäres Gen, das für die antigenischen Determinaten von vier Proteinen aus L. Infantum kodiert |
-
2000
- 2000-08-14 US US09/639,206 patent/US6613337B1/en not_active Expired - Lifetime
-
2001
- 2001-04-05 AT AT01928377T patent/ATE310746T1/de not_active IP Right Cessation
- 2001-04-05 DE DE60115230T patent/DE60115230T2/de not_active Expired - Lifetime
- 2001-04-05 ES ES05025429T patent/ES2391562T3/es not_active Expired - Lifetime
- 2001-04-05 EP EP01928377A patent/EP1287026B1/en not_active Expired - Lifetime
- 2001-04-05 EP EP05025429A patent/EP1681301B1/en not_active Expired - Lifetime
- 2001-04-05 AU AU2001255241A patent/AU2001255241A1/en not_active Abandoned
- 2001-04-05 MX MXPA02010173A patent/MXPA02010173A/es active IP Right Grant
- 2001-04-05 PT PT05025429T patent/PT1681301E/pt unknown
- 2001-04-05 ES ES01928377T patent/ES2255553T3/es not_active Expired - Lifetime
- 2001-04-05 WO PCT/US2001/011254 patent/WO2001079276A2/en active IP Right Grant
- 2001-04-11 AR ARP010101749A patent/AR028333A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1287026B1 (en) | 2005-11-23 |
ES2391562T3 (es) | 2012-11-27 |
ES2255553T3 (es) | 2006-07-01 |
WO2001079276A2 (en) | 2001-10-25 |
AU2001255241A1 (en) | 2001-10-30 |
EP1681301A1 (en) | 2006-07-19 |
EP1287026A2 (en) | 2003-03-05 |
PT1681301E (pt) | 2012-10-26 |
ATE310746T1 (de) | 2005-12-15 |
US6613337B1 (en) | 2003-09-02 |
DE60115230D1 (de) | 2005-12-29 |
DE60115230T2 (de) | 2006-08-03 |
WO2001079276A3 (en) | 2002-09-06 |
EP1681301B1 (en) | 2012-07-18 |
AR028333A1 (es) | 2003-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7242796A (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
MXPA02010173A (es) | Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis. | |
CY2612B2 (en) | Compounds for immunotherapy and diagnosis of tuberculosis | |
PL351893A1 (en) | Vaccines | |
IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
EP1071451A4 (en) | COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS | |
WO1998053075A3 (en) | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use | |
HUP0400231A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
WO1998016646A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
WO2001000232A3 (en) | Use of cpg as an adjuvant for hiv vaccine | |
HUP0103078A2 (hu) | Készítmények és eljárások szürkehályog kezelésére | |
AU2002347152A8 (en) | Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection | |
IS2670B (is) | Bóluefni og notkun þar á til meðhöndlunar á blandaðri hreyfitaugahrörnun | |
WO2007121184A3 (en) | Compounds and methods for diagnosis and treatment of leishmaniasis | |
EP1471936A4 (en) | HIV VACCINE AND METHOD OF USE | |
WO1998035045A3 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
WO2002098359A3 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
WO2001000231A3 (en) | Use of cpg as an adjuvant for malaria vaccine | |
WO1997047271A3 (en) | Cellular vaccines and immunotherapeutics and methods for their preparation | |
EP1422238A3 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
WO2003032895A3 (en) | Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer | |
GB9618119D0 (en) | Adjuvants for use in vaccines | |
WO1999037774A8 (en) | Differentiation-associated sequences and methods of use therefor | |
WO1999037778A3 (en) | Compositions and methods for detecting and treating prostate cancer | |
IL160412A0 (en) | Methods and pharmaceutical compositions for immune deception, particularly in the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |